Search Results - "van Diepen, M."

A meta-review demonstrates improved reporting quality of qualitative reviews following the publication of COREQ- and ENTREQ-checklists, regardless of modest uptake by de Jong, Y, van der Willik, E M, Milders, J, Voorend, C G N, Morton, Rachael L, Dekker, F W, Meuleman, Y, van Diepen, M

“…Reviews of qualitative studies allow for deeper understanding of concepts and findings beyond the single qualitative studies. Concerns on study reporting…”
Get full text

The functional role of alpha-band activity in attentional processing: the current zeitgeist and future outlook by Van Diepen, Rosanne M., Foxe, John J, Mazaheri, Ali

“…•We reviewed the evidence on the role alpha oscillations might play in attention.•There is an abundance of support for alpha power playing a functional…”
Get full text

A functional and structural investigation of the human fronto-basal volitional saccade network by Neggers, Sebastiaan F W, Diepen, Rosanne M van, Zandbelt, Bram B, Vink, Matthijs, Mandl, René C W, Gutteling, Tjerk P

“…Almost all cortical areas are connected to the subcortical basal ganglia (BG) through parallel recurrent inhibitory and excitatory loops, exerting volitional…”
Get full text

Interaction and imbalance between indispensable amino acids in young piglets by Jansman, A. J. M., Cirot, O., Corrent, E., Lambert, W., Ensink, J., van Diepen, J. Th. M.

“…Lowering protein level in diets for piglets urge to have knowledge on the piglet’s requirements for essential amino acids (AA) and their interactions. The…”
Get full text

The Role of Alpha Activity in Spatial and Feature-Based Attention by van Diepen, Rosanne M, Miller, Lee M, Mazaheri, Ali, Geng, Joy J

“…Modulations in alpha oscillations (∼10 Hz) are typically studied in the context of anticipating upcoming stimuli. Alpha power decreases in sensory regions…”
Get full text

Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study by Fu, Edouard L, Evans, Marie, Clase, Catherine M, Tomlinson, Laurie A, van Diepen, Merel, Dekker, Friedo W, Carrero, Juan J

“…It is unknown whether stopping renin-angiotensin system (RAS) inhibitor therapy in patients with advanced CKD affects outcomes. We studied patients referred to…”
Get full text

Merits and caveats of propensity scores to adjust for confounding by Fu, Edouard L, Groenwold, Rolf H H, Zoccali, Carmine, Jager, Kitty J, van Diepen, Merel, Dekker, Friedo W

“…Abstract Proper adjustment for confounding is essential when estimating the effects of treatments or risk factors on health outcomes in observational data. To…”
Get full text

Use of guideline‐recommended medical therapy in patients with heart failure and chronic kidney disease: from physician's prescriptions to patient's dispensations, medication adherence and persistence by Janse, Roemer J., Fu, Edouard L., Dahlström, Ulf, Benson, Lina, Lindholm, Bengt, Diepen, Merel, Dekker, Friedo W., Lund, Lars H., Carrero, Juan‐Jesus, Savarese, Gianluigi

“…Aim Half of heart failure (HF) patients have chronic kidney disease (CKD) complicating their pharmacological management. We evaluated physicians' and patients'…”
Get full text

Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study by Fu, Edouard L., Clase, Catherine M., Evans, Marie, Lindholm, Bengt, Rotmans, Joris I., Dekker, Friedo W., van Diepen, Merel, Carrero, Juan-Jesus

“…It is unknown whether initiating renin-angiotensin system (RAS) inhibitor therapy in patients with advanced chronic kidney disease (CKD) is superior to…”
Get full text

A tool to predict the risk of lower extremity amputation in patients starting dialysis by Akerboom, Bram, Janse, Roemer J, Caldinelli, Aurora, Lindholm, Bengt, Rotmans, Joris I, Evans, Marie, van Diepen, Merel

“…Non-traumatic lower extremity amputation (LEA) is a severe complication during dialysis. To inform decision-making for physicians, we developed a multivariable…”
Get full text

Lessons learnt when accounting for competing events in the external validation of time-to-event prognostic models by Ramspek, Chava L, Teece, Lucy, Snell, Kym I E, Evans, Marie, Riley, Richard D, van Smeden, Maarten, van Geloven, Nan, van Diepen, Merel

“…Abstract Background External validation of prognostic models is necessary to assess the accuracy and generalizability of the model to new patients. If models…”
Get full text

Clinical impact of the Kidney Failure Risk Equation for vascular access planning by Lundström, Ulrika Hahn, Ramspek, Chava L, Dekker, Friedo W, van Diepen, Merel, Carrero, Juan Jesus, Hedin, Ulf, Evans, Marie

“…Risk-based thresholds for arteriovenous (AV) access creation has been proposed to aid vascular access planning. We aimed to assess the clinical impact of…”
Get full text

Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome them by Fu, Edouard L, van Diepen, Merel, Xu, Yang, Trevisan, Marco, Dekker, Friedo W, Zoccali, Carmine, Jager, Kitty, Carrero, Juan Jesus

“…Observational pharmacoepidemiological studies using routinely collected healthcare data are increasingly being used in the field of nephrology to answer…”
Get full text

Comprehensive comparison of stroke risk score performance: a systematic review and meta-analysis among 6 267 728 patients with atrial fibrillation by van der Endt, Vera H W, Milders, Jet, Penning de Vries, Bas B L, Trines, Serge A, Groenwold, Rolf H H, Dekkers, Olaf M, Trevisan, Marco, Carrero, Juan J, van Diepen, Merel, Dekker, Friedo W, de Jong, Ype

“…Multiple risk scores to predict ischaemic stroke (IS) in patients with atrial fibrillation (AF) have been developed. This study aims to systematically review…”
Get full text

Kidney function and symptom development over time in elderly patients with advanced chronic kidney disease: results of the EQUAL cohort study by Janmaat, Cynthia J, van Diepen, Merel, Meuleman, Yvette, Chesnaye, Nicholas C, Drechsler, Christiane, Torino, Claudia, Wanner, Christoph, Postorino, Maurizio, Szymczak, Maciej, Evans, Marie, Caskey, Fergus J, Jager, Kitty J, Dekker, Friedo W

“…Initiation of renal replacement therapy often results from a combination of kidney function deterioration and symptoms related to chronic kidney disease (CKD)…”
Get full text

Correlation of haemagglutinin-neuraminidase and fusion protein content with protective antibody response after immunisation with inactivated Newcastle disease vaccines by Maas, R.A., Komen, M., van Diepen, M., Oei, H.L., Claassen, I.J.T.M.

“…The correlation between the antigen content of inactivated Newcastle disease (ND) oil emulsion–vaccines and the serological response after immunisation was…”
Get full text

Association of Acute Increases in Plasma Creatinine after Renin-Angiotensin Blockade with Subsequent Outcomes by Fu, Edouard L, Trevisan, Marco, Clase, Catherine M, Evans, Marie, Lindholm, Bengt, Rotmans, Joris I, van Diepen, Merel, Dekker, Friedo W, Carrero, Juan-Jesus

“…Data from observational and interventional studies provide discordant results regarding the relationship between creatinine increase after renin-angiotensin…”
Get full text

The impact of symptoms on health-related quality of life in elderly pre-dialysis patients: effect and importance in the EQUAL study by Voskamp, Pauline W M, van Diepen, Merel, Evans, Marie, Caskey, Fergus J, Torino, Claudia, Postorino, Maurizio, Szymczak, Maciej, Klinger, Marian, Wallquist, Carin, van de Luijtgaarden, Moniek W M, Chesnaye, Nicolas C, Wanner, Christoph, Jager, Kitty J, Dekker, Friedo W

“…Abstract Background Quality of life (QoL) is an important outcome in chronic kidney disease (CKD). Patients feel that symptoms are an important determinant of…”
Get full text

Characteristics of chest pain in COVID-19 patients in the emergency department by Sinkeldam, M., Buenen, A. G., Celiker, E., van Diepen, M., de Vos, A. M.

“…Introduction Patients with coronavirus disease 2019 (COVID-19) can present with chest pain. However, the characteristics of this chest pain are unknown. We…”
Get full text

Uric acid is not associated with decline in renal function or time to renal replacement therapy initiation in a referred cohort of patients with Stage III, IV and V chronic kidney disease by Nacak, Hakan, van Diepen, Merel, Qureshi, Abdul R, Carrero, Juan J, Stijnen, Theo, Dekker, Friedo W, Evans, Marie

“…Although many studies have suggested an association between higher uric acid (UA) and both development of chronic kidney disease (CKD) and faster decline in…”
Get full text